Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2007-10-16
2007-10-16
Monshipouri, Maryam (Department: 1656)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001730, C424S501000
Reexamination Certificate
active
11284734
ABSTRACT:
The invention discloses the nanoparticles composed of chitosan, poly-γ-glutamic acid, and at least one bioactive agent characterized with a positive surface charge and their enhanced permeability for paracellular drug delivery.
REFERENCES:
patent: 5510118 (1996-04-01), Bosch et al.
patent: 5620708 (1997-04-01), Amkraut et al.
patent: 5641515 (1997-06-01), Ramtoola
patent: 5702727 (1997-12-01), Amkraut et al.
patent: 5962019 (1999-10-01), Cho et al.
patent: 5972389 (1999-10-01), Shell et al.
patent: 6197757 (2001-03-01), Perrier et al.
patent: 6346613 (2002-02-01), O'Mahony et al.
patent: 6517869 (2003-02-01), Park et al.
patent: 6632457 (2003-10-01), Sawhney
patent: 6638918 (2003-10-01), Davison et al.
patent: 6726934 (2004-04-01), Prokop
patent: 6770299 (2004-08-01), Muller et al.
patent: 6933331 (2005-08-01), Yadav et al.
ven der Lubben et al., Eur. J. Pharm. Sci., 14, 201-207, 2001.
Liang Hsiang-Fa
Lin Yu-Hsin
Sung Hsing-Wen
Tu Hosheng
GP Medical, Inc.
Monshipouri Maryam
National Tsing Hua University
LandOfFree
Nanoparticles for protein drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanoparticles for protein drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticles for protein drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3893898